Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 10:12 PM
Ignite Modification Date: 2025-12-25 @ 7:47 PM
NCT ID: NCT04343235
Description: Adverse events were used according to the clinicaltrials.gov definitions.
Frequency Threshold: 0
Time Frame: 2 weeks
Study: NCT04343235
Study Brief: Postpartum Management of Gestational Hypertensive Disorders Using Furosemide
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Labetalol + Furosemide labetalol + furosemide furosemide: five day course of furosemide 20mg QD labetalol: 200mg labetalol BID 0 None 0 6 0 6 View
Labetalol Only labetalol only labetalol: 200mg labetalol BID 0 None 0 7 0 7 View
Serious Events(If Any):
Other Events(If Any):